dehydrocostus lactone has been researched along with Benign Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Ding, YH; Gao, X; Kuang, BJ; Long, J; Zhang, Q | 1 |
1 other study(ies) available for dehydrocostus lactone and Benign Neoplasms
Article | Year |
---|---|
Dispirocyclopropyldehydrocostus lactone selectively inhibits acute myelogenous leukemia cells.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Lactones; Leukemia, Myeloid, Acute; Mice; Mice, SCID; Neoplasms; Poly(ADP-ribose) Polymerases; Prodrugs; Sesquiterpenes; Transplantation, Heterologous; Up-Regulation | 2016 |